News – Page 970 – Endpoints News

Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days

7 years ago

Zafgen has something to cheer as diabetes drug makes the cut in PhII study

7 years ago

Short seller Citron draws fresh blood going after another biotech scalp — but can it still cut that deep?

7 years ago

Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt

7 years ago

Second time's a charm for osteoporosis drug from Amgen, UCB as FDA panel grants its blessing

7 years ago

FDA revises draft guidance on rare disease drug R&D

7 years ago

AstraZeneca signs deal to promote product made in China — in mainland China; Israeli deep brain stimulation co ...

7 years ago

Dragonfly preps clinical takeoff, inking a collaboration pact with MD Anderson

7 years ago

Aptinyx shares crater as lead drug fails in PhII neuropathic pain study

7 years ago

Allergan and its Mohawk allies pitch their sovereign immunity case to SCOTUS. And the timing couldn't be worse

7 years ago

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-backed I/O drug

7 years ago

Live to 150? Jim Mellon and the crew at Juvenescence just raised $46M more to give it a try

7 years ago

Five Prime cuts 41 jobs, days before presenting data at ASCO meeting of GI cancers

7 years ago

Gottlieb, Marks detail plans to advance development of cell and gene therapies

7 years ago

Harvard prof David Sinclair backs anti-aging upstart Life Bio, which just raised $50M for research

7 years ago

Seres promotes CFO Eric Shaff to succeed Pomerantz as CEO; Exelixis' Cabometyx bags US approval for liver cancer

7 years ago

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for ...

7 years ago

Two more big pharma vets at Roche, AstraZeneca make the leap to top biotech R&D jobs as the great migration continues

7 years ago

Cummings triggers probe into pricing practices of dozen major drugmakers

7 years ago

May the candle burn forever: Polite reminders about the JPMorgan confab

7 years ago

Merck highlights crucial hit for Keytruda in second-line esophageal carcinoma — but there are also 2 misses

7 years ago

Aimmune says US government shutdown stymied its peanut allergy drug application

7 years ago

Scoop: Pfizer once again takes out the budget ax, lopping off 150 R&D staffers and 5 preclinical biosimilar drugs

7 years ago

EMA to lose 25% of staff as hard Brexit approaches

7 years ago

First page Previous page 967 968 969970971 972 973 Next page Last page